Sex differences in the response of children with ADHD to once-daily formulations of Methylphenidate
Sex differences in the response of children with ADHD to once-daily formulations of Methylphenidate
Objectives: Studies of sex differences in methylphenidate response by children with attention-deficit/hyperactivity disorder have lacked methodological rigor and statistical power. This paper reports an examination of sex differences based on further analysis of data from a comparison of two once-daily methylphenidate formulations (the COMACS study), which addresses these shortcomings.
Method: Children (184: 48 females; mean [SD] age, 9.58 [1.83] years) entered a double-blind, crossover trial of Concerta, MetadateCD/Equasym XL, or placebo. Attention-deficit/hyperactivity disorder symptoms were recorded at seven time points across the school day on the seventh day of treatment, using a laboratory classroom setting.
Results: More females had comorbid anxiety disorder. Males and females did not differ with regard to other characteristics. Observed sex differences in pharmacodynamic symptom profiles persisted after controlling for placebo and time 0 hours attention-deficit/hyperactivity disorder scores and the presence of an anxiety disorder. Females had a statistically superior response at 1.5 hours post-dosing and an inferior response at the 12-hour time point relative to their male counterparts, no matter which methylphenidate formulation was being assessed.
Conclusions: Dose titration of once-daily formulations of methylphenidate should ideally be based on systematic evidence of response at different periods across the day. The responses of female patients may require additional assessments later in the day to determine the optimal dose.
701-710
Sonuga-Barke, E.J.S.
bc80bf95-6cf9-4c76-a09d-eaaf0b717635
Coghill, D.
a4b982d1-4788-41aa-90c5-b4a7f7dffad7
Markowitz, J.S.
fcb4b3a8-39c3-45be-b2b8-8f757ccea295
Swanson, J.M.
745c2c76-3510-4542-850d-4d084f748b2c
Vandenberghe, M.
6bebf94b-30a0-4963-9c21-adc9b02b9a5d
Hatch, S.
4b6224bb-6a4e-49b2-9703-0a84d5d12525
2007
Sonuga-Barke, E.J.S.
bc80bf95-6cf9-4c76-a09d-eaaf0b717635
Coghill, D.
a4b982d1-4788-41aa-90c5-b4a7f7dffad7
Markowitz, J.S.
fcb4b3a8-39c3-45be-b2b8-8f757ccea295
Swanson, J.M.
745c2c76-3510-4542-850d-4d084f748b2c
Vandenberghe, M.
6bebf94b-30a0-4963-9c21-adc9b02b9a5d
Hatch, S.
4b6224bb-6a4e-49b2-9703-0a84d5d12525
Sonuga-Barke, E.J.S., Coghill, D., Markowitz, J.S., Swanson, J.M., Vandenberghe, M. and Hatch, S.
(2007)
Sex differences in the response of children with ADHD to once-daily formulations of Methylphenidate.
Journal of the American Academy of Child and Adolescent Psychiatry, 46 (6), .
Abstract
Objectives: Studies of sex differences in methylphenidate response by children with attention-deficit/hyperactivity disorder have lacked methodological rigor and statistical power. This paper reports an examination of sex differences based on further analysis of data from a comparison of two once-daily methylphenidate formulations (the COMACS study), which addresses these shortcomings.
Method: Children (184: 48 females; mean [SD] age, 9.58 [1.83] years) entered a double-blind, crossover trial of Concerta, MetadateCD/Equasym XL, or placebo. Attention-deficit/hyperactivity disorder symptoms were recorded at seven time points across the school day on the seventh day of treatment, using a laboratory classroom setting.
Results: More females had comorbid anxiety disorder. Males and females did not differ with regard to other characteristics. Observed sex differences in pharmacodynamic symptom profiles persisted after controlling for placebo and time 0 hours attention-deficit/hyperactivity disorder scores and the presence of an anxiety disorder. Females had a statistically superior response at 1.5 hours post-dosing and an inferior response at the 12-hour time point relative to their male counterparts, no matter which methylphenidate formulation was being assessed.
Conclusions: Dose titration of once-daily formulations of methylphenidate should ideally be based on systematic evidence of response at different periods across the day. The responses of female patients may require additional assessments later in the day to determine the optimal dose.
This record has no associated files available for download.
More information
Published date: 2007
Identifiers
Local EPrints ID: 48228
URI: http://eprints.soton.ac.uk/id/eprint/48228
ISSN: 1527-5418
PURE UUID: 609ae75c-7ada-4d55-a364-d5bb75356025
Catalogue record
Date deposited: 06 Sep 2007
Last modified: 08 Jan 2022 03:59
Export record
Contributors
Author:
E.J.S. Sonuga-Barke
Author:
D. Coghill
Author:
J.S. Markowitz
Author:
J.M. Swanson
Author:
M. Vandenberghe
Author:
S. Hatch
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics